C. Paoletti

发表

A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization.

J. Lepecq, C. Paoletti, J B LePecq, 1967, Journal of molecular biology.

Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol.

L. Mir, C. Paoletti, H. Banoun, 1988, Experimental cell research.

Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs.

L. Mir, C. Paoletti, S. Orlowski, 1988, Biochemical pharmacology.

α-DNA IV: α-anomeric and β-anomeric tetrathymidylates covalently linked to intercalating oxazolopyridocarbazole. Synthesis, physicochemical properties and poly (rA) binding

C. Paoletti, T. Huynh-Dinh, B. Rayner, 1987 .

Infectious and Oncogenic Effect of DNA Extracted from Cells Infected with Polyoma Virus

M. Boiron, C. Paoletti, G. Orth, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Lack of single-strand DNA-binding protein amplification under conditions of SOS induction in E. coli

C. Paoletti, B. Salles, G. Villani, 2004, Molecular and General Genetics MGG.

Metabolism of ellipticine and derivatives and its involvement in the antitumor action of these drugs

D. Mansuy, C. Paoletti, P. Lesca, 1978 .

Voltage-dependent introduction of a d[α]octothymidylate into electropermeabilized cells

L. Mir, C. Paoletti, D. Bazile, 1989 .

Comparative activity of alpha- and beta-anomeric oligonucleotides on rabbit beta globin synthesis: inhibitory effect of cap targeted alpha-oligonucleotides.

C. Paoletti, C. Malvy, J. Bertrand, 1989, Biochemical and biophysical research communications.

Comparative activity of α- and β-anomeric oligonucleotides on rabbit β globin synthesis: Inhibitory effect of cap targeted α-oligonucleotides

C. Paoletti, C. Malvy, J. Bertrand, 1989 .

Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile.

M. Maftouh, B. Monsarrat, C. Paoletti, 1984, Drug metabolism and disposition: the biological fate of chemicals.

Purification and properties of an acid deoxyribonuclease from the snail Helix aspersa Müll.

C. Paoletti, J. Laval, 1972, Biochemistry.

Bis(pyrrolecarboxamide) linked to intercalating chromophore oxazolopyridocarbazole (OPC): selective binding to DNA and polynucleotides.

C. Paoletti, J. Imbach, C. Auclair, 1991, Biochemistry.

Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.

C. Paoletti, C. Auclair, 1981, Journal of medicinal chemistry.

The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated rats.

C. Paoletti, P. Lesca, P. Lecointe, 1977, Biochemical pharmacology.

Control of UV induction of recA protein (Escherichia coli/UV irradiation/SOS functions/recF/immunoradiometric assay)

C. Paoletti, B. Salles, 2016 .

Synergic effect of NADP+ on the antitumor properties of low doses of 9 OH-ellipticine towards Walker cells.

C. Paoletti, C. Malvy, 1983, European journal of cancer & clinical oncology.

A new antitumoral agent: 9-hydroxyellipticine. Possibility of a rational design of anticancerous drugs in the series of DNA intercalating drugs.

C. Paoletti, J. Le Pecq, J. L. Pecq, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites

B. Monsarrat, J. Armand, C. Paoletti, 2004, Cancer Chemotherapy and Pharmacology.

Oxidative biotransformation of the antitumour agent elliptinium acetate: Structural characterization of its human and rat urinary metabolites.

M. Maftouh, B. Monsarrat, J. Armand, 1987, Journal of pharmaceutical and biomedical analysis.

Covalent binding of the antitumor agent N2-methyl-9-hydroxy-ellipticinium acetate (NSC 264137) on RNA and poly A in vitro.

C. Paoletti, B. Meunier, B. Dugué, 1984, Biochemical and biophysical research communications.

Bis-Pyrrolecarboxamides Linked to Intercalating Chromophore Oxazolopyridocarbazole (OPC): Properties Related to the Selective Binding to DNA at Rich Sequences

C. Paoletti, J. Imbach, C. Auclair, 1990 .

Peroxidase-catalysed covalent binding of the antitumor drug 2N-methyl-9-hydroxy-ellipticine to proteins.

C. Paoletti, B. Meunier, C. Auclair, 1983, Biochemical pharmacology.

Autoxidation of the antitumor drug 9-hydroxyellipticine and its derivatives.

C. Paoletti, C. Auclair, K. Hyland, 1983, Journal of medicinal chemistry.

omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.

C. Paoletti, B. Meunier, J. Bernadou, 1983, Journal of medicinal chemistry.

Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemia.

C. Paoletti, A. Moisand, N. Xuong, 1979, Chemico-biological interactions.

Efficient breakage of DNA apurinic sites by the indoleamine related 9-amino-ellipticine.

C. Paoletti, C. Malvy, P. Prevost, 1986, Chemico-biological interactions.

Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.

C. Paoletti, B. Meunier, J. Bernadou, 1984, Proceedings of the National Academy of Sciences of the United States of America.

O-QUINONE FORMATION IN THE BIOCHEMICAL OXIDATION OF THE ANTITUMOR DRUG N2-METHYL-9-HYDROXYELLIPTICINIUM ACETATE

C. Paoletti, B. Meunier, J. Bernadou, 1983 .

Unexpected regiospecific alkylation of the antitumor agent N2-methyl-9-hydroxyellipticinium acetate with N, O or S donors

C. Paoletti, B. Meunier, J. Bernadou, 1983 .

BIOACTIVATION OF THE ANTITUMOR DRUGS 9-HYDROXYELLIPTICINE AND DERIVATIVES BY A PEROXIDASE-HYDROGEN PEROXIDE SYSTEM

C. Paoletti, C. Auclair, 1981 .

Antitumor activity, pharmacology, and toxicity of ellipticines, ellipticinium, and 9-hydroxy derivatives: preliminary clinical trials of 2-methyl-9-hydroxy ellipticinium (NSC 264-137).

C. Paoletti, J. Le Pecq, H. Garnier, 1980, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Selective binding of elliptinium acetate onto the 3'-terminal ribose of diribonucleosides monophosphates.

E. Guittet, C. Paoletti, J. Lallemand, 1985, Biochemical and biophysical research communications.

Synthesis of (O)-glucosides of N2-methyl-9-hydroxyellipticinium and related biological studies

C. Paoletti, B. Meunier, B. Dugué, 1984 .

Antitumor Activity, Pharmacology and Clinical Trials of Elliptinium (NSC 264-137)

C. Paoletti, A. Larsen, 1986 .

Regioselective 2′-O Sugar Arylation in Adenine Nucleosides by The Elliptinium Agetate, An Antitumor Agent

C. Paoletti, B. Meunier, G. Pratviel, 1985 .

Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivatives.

C. Paoletti, H. Banoun, B. Meunier, 1984, Journal of medicinal chemistry.

A revised structure of the antitumor drug elliptinium--amino(acid) adducts.

C. Paoletti, C. Auclair, A. Gouyette, 1985, Biochemical and biophysical research communications.

Mechanism of deoxyribonucleic acid degradation by an acid deoxyribonuclease from the snail Helix aspersa Müll.

C. Paoletti, J. Laval, 1972, Biochemistry.

Sequence requirements for mammalian topoisomerase II mediated DNA cleavage stimulated by an ellipticine derivative.

C. Paoletti, P. Fossé, M. Le Bret, 1991, Nucleic acids research.

A protein inhibitor of acid deoxyribonucleases.

C. Paoletti, P. Lesca, 1969, Proceedings of the National Academy of Sciences of the United States of America.

Stimulation by γ-carboline derivatives (simplified analogues of antitumor ellipticines) of site specific DNA cleavage by calf DNA topoisomerase II

C. Nguyen, C. Paoletti, P. Fossé, 1990 .

α-DNA VI: comparative study of α- and β-anomeric oligodeoxyribonucleotides in hybridization to mRNA and in cell free translation inhibition

C. Paoletti, B. Lebleu, C. Malvy, 1987 .

Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. 1. Purification and properties.

A. Jacquemin-Sablon, C. Paoletti, H. Jacquemin-Sablon, 1979, Biochemistry.

A carboline derivative as a novel mammalian DNA topoisomerase II targeting agent.

F. Pognan, C. Paoletti, L. Kaczmarek, 1992, Biochemical pharmacology.

Binding of ellipticine base and ellipticinium cation to calf-thymus DNA. A thermodynamic and kinetic study.

G. Dodin, C. Paoletti, J. Aubard, 1988, European journal of biochemistry.

Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.

C. Paoletti, F. Lavelle, S. Giorgi-Renault, 1991, Journal of medicinal chemistry.

Structure-activity relationships in the inhibitory effects of ellipticines on benzo(a)pyrene hydroxylase activity and 3-methylcholanthrene mutagenicity.

D. Mansuy, C. Paoletti, D. Pélaprat, 1980, Biochemical pharmacology.

Synthesis, DNA binding and biological activity of oxazolopyridocarbazole-netropsin hybrid molecules

C. Paoletti, J. Balzarini, E. Clercq, 1991 .

Synthesis, DNA binding properties and biological evaluation of novel oligo-meta-benzamides related to netropsin

C. Paoletti, J. Balzarini, E. Clercq, 1991 .

A new fluorometric method for RNA and DNA determination.

C. Paoletti, J. Le Pecq, J. L. Pecq, 1966, Analytical biochemistry.

A new series of ellipticine derivatives (1-(alkylamino)-9-methoxyellipticine). Synthesis, DNA binding, and biological properties.

L. Larue, C. Paoletti, E. Bisagni, 1988, Journal of medicinal chemistry.

Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.

P. Gros, C. Paoletti, C. Auclair, 1987, Cancer research.

Progress in Molecular and Subcellular Biology 3

A. S. Braverman, K. R. Ely, B. P. Doctor, 1973, Progress in Molecular and Subcellular Biology.

Chemical structure of ethidium bromide metabolites extracted from rat bile

B. Roques, C. Paoletti, B. Gaugain, 1981, FEBS letters.

Effects of 9‐hydroxyellipticine on growth and macromolecular synthesis in Escherichia coli

C. Paoletti, R. Alazard, P. Boquet, 1976, FEBS letters.

Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.

C. Paoletti, B. Meunier, C. Auclair, 1986, Biochemistry.

Stacking and edge‐to‐edge associations of antitumoral ellipticine derivatives are controlled in solution by interactions involving their nitrogen sites

C. Paoletti, B. Perly, C. Auclair, 1988, Biopolymers.

The hepatic metabolism of ethidium bromide to reactive mutagenic species: biochemical and structural requirements.

C. Paoletti, C. Fraire, P. Lecointe, 1981, Biochemical pharmacology.

The use of ethidium bromide-circular DNA complexes for the fluorometric analysis of breakage and joining of DNA.

I. Lehman, J. Lepecq, C. Paoletti, 1971, Journal of molecular biology.

Preparation and properties of nuclear and satellite deoxyribonucleic acid of Trypanosoma cruzi.

G. Riou, C. Paoletti, 1967, Journal of molecular biology.

Structural changes of polyriboinosinic acid induced by a steroidal diamine, irehdiamine A.

C. Paoletti, J. Saucier, P. Lefresne, 1967, Biochemical and biophysical research communications.

Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses.

L. Mir, C. Paoletti, S. Orlowski, 1991, European journal of cancer.

Interactions between ellipticine and some derivatives and phospholipids in model membranes

C. Paoletti, J. Tocanne, E. M. El Mashak, 1979, FEBS letters.

Ellipticines as potent inhibitors of aryl hydrocarbon hydroxylase: their binding to microsomal cytochromes P450 and protective effect against benzo(a)pyrene mutagenicity.

D. Mansuy, C. Paoletti, P. Lesca, 1978, Biochemical pharmacology.

Ethidium bromide mutagenesis in yeast: protection by anaerobiosis.

C. Paoletti, M. Guérineau, M. Pinto, 1975, Mutation research.

Relationship between cytostatic activity of oxazolopyridocarbazoles and accessibility of DNA intercalation sites in living bacteria.

C. Paoletti, H. Banoun, C. Auclair, 1986, Biochemistry.

Mechanism of cleavage of apurinic sites by 9-aminoellipticine.

C. Paoletti, C. Malvy, J. Bertrand, 1989, The Journal of biological chemistry.

Electrochemotherapy of spontaneous mammary tumours in mice.

L. Mir, C. Paoletti, S. Orlowski, 1991, European journal of cancer.

Initial degradation of deoxyribonucleic acid after injection in mammals.

C. Paoletti, J. Le Pecq, P. Defrance, 1965, Cancer research.

Urinary β-Amino Isobutyric Acid in the Mouse: Elimination after Intravenous Administration of Deoxyribonucleic Acid

C. Paoletti, R. Truhaut, E. Delacoux, 1965, Nature.

[Induction of rat hepatic mono-oxygenases by ellipticine: formation of cytochrome p448. Hydroxylating activity].

D. Mansuy, C. Paoletti, P. Lesca, 1976, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles.

α-DNA II. Synthesis of unnatural α-anomeric oligodeoxyribonucleotides containing the four usual bases and study of their substrate activities for nucleases

C. Paoletti, C. Malvy, J. Bertrand, 1987 .

α-Oligodeoxynucleotide Analogues

C. Paoletti, B. Lebleu, C. Malvy, 1989 .

α-DNA VIII: thermodynamic parameters of complexes formed between the oligo-alpha-deoxynucleotides: α-d(GGAAGG) and α-d(CCTTCC) and their complementary oligo-beta-deoxynucleotides: β-d(CCTTCC) and β-d(GGAAGG) are different

C. Paoletti, J. Imbach, D. Bazile, 1989 .

Anti-sense oligonucleotides as potential antitumour agents: prospective views and preliminary results.

C. Paoletti, 1988, Anti-cancer drug design.

Inhibition of moloney murine leukemia virus reverse transcriptase by α-anomeric oligonucleotides

C. Paoletti, C. Malvy, J. Bertrand, 1989 .

α-Anomeric DNA: β-RNA hybrids as new synthetic inhibitors of Escherichia coli RNase H, Drosophila embryo RNase H and M-MLV reverse transcriptase

F. Pognan, C. Paoletti, C. Malvy, 1988 .

α -DNA X: α and β tetrathymidilates covalently linked to oxazolopyridocarbazolium (OPC): comparative stabilization of oiigo β -[dT]:oligo β -[dA] and oligo α -[dT]:oligo β -[dA] duplexes by the intercalating agent

C. Paoletti, B. Rayner, J. Imbach, 1989 .

Antitumor activity of 9-hydroxyellipticine (NSC 210717) ON L1210 mouse leukemia and the effect of route of injection.

C. Paoletti, J. Le Pecq, S. Cros, 1976, Cancer research.

Studies on the specificity of an acid deoxyribonuclease from Helix aspersa (Müll.).

S. Ehrlich, G. Bernardi, J. Thiery, 1973, European journal of biochemistry.

Synthesis, thermal stability and reactivity towards 9-aminoellipticine of double-stranded oligonucleotides containing a true abasic site.

C. Paoletti, C. Malvy, J. Bertrand, 1989, Nucleic acids research.

The G.C base-pair preference of 2-N-methyl 9-hydroxyellipticinium.

G. Dodin, C. Paoletti, J. Aubard, 1989, European journal of biochemistry.

Apurinic DNA: Modelisation and Reactivity Towards 9-Aminoellipticine and Related Amines

C. Paoletti, C. Malvy, J. Bertrand, 1989 .

An analytical study of the dimerization of in vitro generated RNA of Moloney murine leukemia virus MoMuLV.

C. Ehresmann, J. Darlix, C. Paoletti, 1990, Nucleic acids research.

Different levels of induction of RecA protein in E. coli (PQ 10) after treatment with two related carcinogens.

R. Fuchs, C. Paoletti, B. Salles, 1983, Nucleic acids research.

A yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide.

C. Paoletti, M. Guérineau, H. Couder, 1972, Biochemical and biophysical research communications.

cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA

C. Gabus, J. Darlix, A. Prats, 1990, Journal of virology.

The localization of topoisomerase II cleavage sites on DNA in the presence of antitumor drugs.

C. Paoletti, 1993, Pharmacology & therapeutics.

Control of UV induction of recA protein.

C. Paoletti, B. Salles, C Paoletti, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Yeast mitochondrial deoxyribonuclease stimulated by ethidium bromide. 2. Mechanism of enzyme activation.

A. Jacquemin-Sablon, C. Paoletti, M. Le Bret, 1979, Biochemistry.

Purification and characterization of recA protein from salmonella typhimurium.

C. Paoletti, A. Pierré, 1983, The Journal of biological chemistry.

[Mitochondrial DNA of malignant cells].

G. Riou, C. Paoletti, 1970, Bulletin du cancer.

Characterization of a new class of circular DNA molecules in yeast.

P. Slonimski, C. Paoletti, M. Guérineau, 1971, Biochemical and biophysical research communications.

Rearrangement of mitochondrial DNA molecules during the differentiation of mitochondria in yeast. II. - Labelling studies of the precursor product relationship.

C. Paoletti, M. Guérineau, 1975, Biochimie.

[Electrochemotherapy, a new antitumor treatment: first clinical trial].

L. Mir, C. Paoletti, S. Orlowski, 1991, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Use of a new DNA intercalating fluorescing probe for studies on the mechanism of frameshift mutagenesis in Salmonella typhimurium.

C. Paoletti, H. Banoun, C. Auclair, 1985, Biochimie.

25 Inhibition of the in vitro growth rate of L1210 leukemic cells by platinum(II) derivatives

C. Paoletti, J. Macquet, J. Butour, 1978 .

Relative efficiencies of a series of square-planar plantinum(II) compounds on Salmonella mutagenesis.

C. Paoletti, J. Macquet, J. Butour, 1977, Mutation research.

Does cruciform DNA provide a recognition signal for DNA-topoisomerase II?

F. Pognan, C. Paoletti, 1992, Biochimie.

Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro.

C. Paoletti, C. Malvy, C. Auclair, 1979, Biochemical pharmacology.

Pattern of recognition of DNA by mammalian DNA topoisomerase II.

C. Paoletti, P. Fossé, J. Saucier, 1988, Biochemical and biophysical research communications.

In Vitro Oxidative Activation: A Model for the Cytotoxic Action of 9-Hydroxy Ellipticine Derivatives

M. Maftouh, B. Monsarrat, C. Paoletti, 1983 .

Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates.

M. Maftouh, B. Monsarrat, C. Paoletti, 1983, Xenobiotica; the fate of foreign compounds in biological systems.

Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiae.

C. Paoletti, M. Guérineau, M. Pinto, 1982, Biochemical pharmacology.

Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers.

C. Paoletti, J. Le Pecq, A. Tanguy, 1978, European journal of cancer.

Some antitumor derivatives of ellipticine deprived of mutagenic properties.

C. Paoletti, P. Lesca, P. Lecointe, 1978, Chemico-biological interactions.

Synthesis of 11-amino-substituted-9-methoxy-5-methyl-6H-pyrido[4,3-b]-carbazoles

C. Paoletti, E. Bisagni, C. Rivalle, 1991 .

Frameshift mutagenesis in Escherichia coli by reversible DNA intercalators: sequence specificity.

R. Fuchs, C. Paoletti, C. Auclair, 1988, Mutation research.

Toxicological and pharmacological studies on 9-hydroxy-ellipticine in mice.

C. Paoletti, P. Lecointe, S. Cros, 1975, Toxicology and applied pharmacology.

Interest of Quantum Mechanical Calculations for the Design of Anticancerous Drugs in the Series of Ellipticines

C. Paoletti, M. L. Bret, J. L. Pecq, 1974 .

Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship.

C. Paoletti, P. Fossé, J. Saucier, 1992, Molecular pharmacology.

Synthesis and cytotoxic activity of hydroxylated derivatives of olivacine in relation with their biotransformation.

M. Maftouh, B. Monsarrat, C. Paoletti, 1985, Journal of medicinal chemistry.

Measurement of recA protein induction in Salmonella typhimurium: a possible biochemical test for the detection of DNA damaging agents.

C. Paoletti, B. Salles, A. Pierré, 1982, Biochimie.

A spectrofluorometric method for the study of transcription of single-stranded DNA by RNA polymerase.

C. Paoletti, J. Le Pecq, P. Jeanteur, 1966, Biochimica et biophysica acta.

Lipid peroxidation in liver: hydroxy dimethyl carbazole a new potent inhibitor.

C. Paoletti, R. Willson, C. Malvy, 1980, Biochemical and biophysical research communications.

Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.

D. DeMarini, C. Paoletti, A. Hsie, 1983, Cancer research.

Electrophoretic Pattern of Plasma Proteins in Rats treated with Trypan Blue and Ethionine

G. Riou, C. Paoletti, R. Truhaut, 1962, Nature.

An immunoradiometric quantitative assay of Escherichia coli recA protein.

P. Giacomoni, C. Paoletti, B. Salles, 1982, Biochimie.

Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells.

C. Paoletti, J. Belehradek, J. Paoletti, 1986, Cancer research.

Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsin.

E. De Clercq, C. Paoletti, J. Balzarini, 1989, Journal of medicinal chemistry.

Metabolic transformation of 2-methylellipticinium.

C. Paoletti, C. Malvy, 1980, Biochemical and biophysical research communications.

Heterocyclic quinones VIII. Synthesis and anti-neoplastic evaluation of 7-substituted-1H-pyrrolo[3,2-c]quinoline-6,9-diones and 3-substituted-11H-indolo[3,2-c]quinoline-1,4-diones

C. Paoletti, H. Parrot-Lopez, P. Helissey, 1987 .

Ellipticines as potent inhibitors of drug metabolism. Protective effect against chemical mutagenesis and carcinogenesis

D. Mansuy, C. Paoletti, P. Lesca, 1978 .

[Potentiation of the antitumoral effect of electrochemotherapy by immunotherapy with allogeneic cells producing interleukin 2].

L. Mir, P. Kourilsky, C. Paoletti, 1992, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

Metabolism and disposition studies of 9-hydroxyellipticine and 2-methyl-9-hydroxyellipticinium acetate in animals.

C. Paoletti, J. Le Pecq, A. Gouyette, 1980, Cancer treatment reports.

Human and rat urinary metabolites of the antitumor drug Celiptium (N2-methyl-9-hydroxyellipticinium acetate, NSC 264137). Identification of cysteine conjugates supporting the "biooxidative alkylation" hypothesis.

M. Maftouh, B. Monsarrat, J. Armand, 1983, Biochemical pharmacology.

Frameshift lesions induced by oxazolopyridocarbazoles are recognized by the mismatch repair system in Escherichia coli.

C. Paoletti, C. Auclair, B. René, 1988, Mutation research.

In vitro Examination of the Ribonucleic Acid–Deoxyribonucleic Acid–Deoxyribonuclease System in Mammals

C. Paoletti, B. Festy, J. L. Pecq, 1962, Nature.

[17] Fluorometric assay for specific (nickases) and nonspecific endodeoxyribonucleases

C. Paoletti, J. L. Pecq, 1971 .